Loading...

Indivior Pharmaceuticals Inc

INDV•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$33.23
$0.07(0.21%)
U.S. Market opens in NaNh NaNm

Indivior Pharmaceuticals Inc (INDV) Stock Overview

Explore Indivior Pharmaceuticals Inc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.1B
P/E Ratio19.75
EPS (TTM)$1.64
ROE-0.99%
Fundamental Analysis

AI Price Forecasts

1 Month$31.89
3 Months$38.47
1 Year Target$25.20

INDV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Indivior Pharmaceuticals Inc (INDV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.75 and a market capitalization of 4.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.21%
5-Day Change
2.94%
1-Month Change
15.42%
3-Month Change
0.79%
6-Month Change
32.23%
Year-to-Date (YTD) Change
-7.39%
1-Year Change
208.83%
3-Year Change
87.21%
5-Year Change
240.82%
All-Time (Max) Change
212.02%

Contact Information

https://www.indivior.com
804 379 1090
10710 Midlothian Turnpike, North Chesterfield, VA, 23235

Company Facts

1,030 Employees
IPO DateDec 29, 2014
CountryUS
Actively Trading

Frequently Asked Questions